SCHEMBL3724849

SCHEMBL3724849

CC(C)c1n[nH]c2c(NCc3ccccc3Cl)nc(NC3CCCCC3N)nc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 6/20 0.57
CCNA2 P20248 4/20 0.57
CDK1 P06493 4/20 0.57
CCNB1 P14635 4/20 0.57
CDK5 Q00535 3/20 0.57
CDK4 P11802 3/20 0.57
CCND1 P24385 2/20 0.57
CDK5R1 Q15078 2/20 0.57
CCNE1 P24864 4/20 0.50
CCNE2 O96020 3/20 0.47
CCNA1 P78396 2/20 0.47
CCNT1 O60563 2/20 0.45
CDK9 P50750 2/20 0.45
CCNT2 O60583 1/20 0.45
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
BCDIN3D Q7Z5W3 3/20 0.41
CDK6 Q00534 1/20 0.40
CLK1 P49759 9/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3719462 0.90 CDK2 (0.58) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3725148 0.90 CDK2 (0.57) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3722452 0.88 CDK2 (0.72) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3725633 0.87 CDK2 (0.60) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3720158 0.85 CDK2 (0.59) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3724846 0.85 CDK2 (0.79) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3722242 0.84 CDK2 (0.52) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL2904682 0.84 CDK2 (0.66) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3719639 0.83 CDK2 (0.60) CDK2CCNA2CDK1CCNB1CDK5
SCHEMBL3718107 0.82 CDK2 (0.59) CDK2CCNA2CDK1CCNB1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010139288-A1 5,7-DISUBSTITUTED 3-ISOPROPYLPYRAZOLO[4,3-D]PYRIMIDINES FOR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS C3 BIO GMBH (DE) 2010-12-09 WO disclosed